Women's Health News

RSS

FOIA request on Avastin filed with the FDA

Leaders in the battle with the U.S. Food and Drug Administration to retain metastatic breast cancer (mbc) as an indication for the drug Avastin today filed a Freedom of Information Act ("FOIA") request with the FDA.

28 Apr 2011

Trig Medical to launch new standard for labor progression management at ACOG 2011

Trig Medical, Inc. announces the U.S. launch of LaborPro®, the new standard for labor progression management, at the American Congress of Obstetricians and Gynecologists (ACOG) 2011 Annual Clinical Meeting, taking place April 30 – May 4, 2011 in Washington, D.C. Trig Medical will be demonstrating the LaborPro system in Booth #824 during exhibition hours.

28 Apr 2011

Maternal consumption of omega-3 fatty acids during pregnancy reduces risk of childhood obesity

New research shows a possible connection between the risk of childhood obesity and maternal consumption of omega-3 fatty acids during pregnancy. Intake of the omega-3s found in seafood is also linked to reduced risk of recurrent breast cancer, stroke in women and early age-related macular degeneration (AMD).

27 Apr 2011

Columbia requests FDA Priority Review for PROCHIEVE progesterone gel NDA

Columbia Laboratories, Inc., and Watson Pharmaceuticals, Inc., today announced that Columbia has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for PROCHIEVE® (progesterone gel) for the reduction of risk of preterm birth in women with short uterine cervical length in the mid-trimester of pregnancy.

27 Apr 2011

Newer birth control pill raises risk of blood clots

Two human trials in the US and the UK including women from both populations showed that women taking newer forms of oral contraceptives, which include drosperinone, a synthetic version of the hormone progesterone, increased their risk of developing a blood clots by two or three times over those taking older birth control pills that rely on a different form of the hormone known as levonorgestrel.

26 Apr 2011

Merck receives Health Canada approval for GARDASIL to treat HPV in women upto age 45

Today, Merck announced that Health Canada has extended the indication of GARDASIL in women up to the age of 45. Merck's HPV vaccine is now approved for girls and women nine through 45 years of age for the prevention of cervical cancer, vulvar and vaginal cancers, precancerous lesions and genital warts caused by the Human Papillomavirus types 6, 11, 16, 18. Previously, GARDASIL was approved in girls and women nine through 26.

26 Apr 2011

Fibulin-5 protein can help prevent pelvic organ prolapse development in women

Pelvic organ prolapse is a disabling condition that affects almost 50% of women over the age of 50. It occurs when the muscles and ligaments supporting a woman's pelvic organs weaken such that the pelvic organs slip out of place, often protruding into the vagina.

26 Apr 2011

Study: Women use more medications during pregnancy

Researchers from Boston University's Slone Epidemiology Center, in collaboration with the Centers for Disease Control and Prevention and Harvard School of Public Health, have reported widespread and increasing medication use among pregnant women.

26 Apr 2011

Dactinomycin more effective for low-risk gestational tumor treatment

A clinical trial has sifted out the most effective single-drug chemotherapy regimen for quick-growing but highly curable cancers that arise from the placentas of pregnant women.

26 Apr 2011

Mylan launches Letrozole Tablets for hormone receptor-positive early stage breast cancer

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Letrozole Tablets USP, 2.5 mg, under a previously announced settlement and license agreement with Novartis. Mylan was the first company to have filed a substantially complete ANDA containing a Paragraph IV certification for Letrozole Tablets and will market the product with a period of exclusivity.

25 Apr 2011

Planned Parenthood spends $400,000 on first-quarter lobbying

Planned Parenthood's federal lobbying bill more than tripled in the first three months of the new Congress, as Republicans targeted the group for funding cuts and transformed it into a political cause célébre.

25 Apr 2011

Rwanda, QIAGEN and Merck launch comprehensive national cervical cancer prevention program

The Government of Rwanda, together with QIAGEN N.V. and Merck, known as MSD outside the United States and Canada, today announced the launch, in Kigali, Rwanda, of a comprehensive national cervical cancer prevention program that includes vaccination with GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] for appropriate girls 12 to 15 years of age and modern molecular diagnostic screening for women between the ages of 35 and 45.

From QIAGEN Manchester Limited 25 Apr 2011

Urologic Nursing publishes NAFC nocturia research in middle-aged American women

Research by the National Association For Continence about nocturia in middle-aged American women appears in the current issue of Urologic Nursing, the official journal of the Society of Urologic Nurses and Associates.

22 Apr 2011

Political discourse regarding Planned Parenthood moves to states

Media outlets report on state-level action regarding Planned Parenthood and abortion issues.

22 Apr 2011

CTIS Pregnancy Health Information Line aims to educate women about meningitis

The California Teratogen Information Service Pregnancy Health Information Line, a state-wide non-profit organization based at the University of California, San Diego with affiliates across North America, will join in the effort to raise awareness of meningitis prevention by helping to launch a new study that will assess safety of the meningitis vaccine in pregnancy.

22 Apr 2011

Contraception drospirenone raises risk for blood clots

Two new drug safety studies conducted by researchers at Boston University School of Medicine (BUSM) provide strong evidence that women taking oral contraception with drospirenone have an increased risk of nonfatal venous thromboembolism, or blood clots, compared to women taking oral contraception with levonorgestrel.

21 Apr 2011

Merrimack initiates dosing in MM-111 combination Phase 1 study in advanced HER2 positive patients

Merrimack Pharmaceuticals, Inc. announced today that five patients have received therapy in a Phase I clinical study combining MM-111 with multiple standard treatment regimens for patients with advanced HER2 positive (HER2+) solid tumors.

21 Apr 2011

Providing complete information about breast cancer treatment options often ends up overwhelming patients

Women who choose among different breast cancer treatment options make smarter choices when getting the information and making decisions in small doses rather than all at once, as is customary, a University of Michigan study found.

21 Apr 2011

US-LACRN selects Agilent gene expression microarrays for major breast cancer study

Agilent Technologies Inc. today announced that the United States-Latin American Cancer Research Network has selected Agilent Gene Expression microarrays and associated instruments for a major study of breast cancer in five Latin American nations.

21 Apr 2011

Roundup: Abortion opponents weigh strategy; Supreme Court reinstates case involving deaths at Va. hospitals

Republican legislatures across the country are passing tough new anti-abortion laws — and while abortion rights advocates believe the new laws are unconstitutional, they're not rushing to court to stop them. The reason: There's a decent chance they'd lose (Kliff, 4/20).

21 Apr 2011

Women's Health News

FOIA request on Avastin filed with the FDA

Trig Medical to launch new standard for labor progression management at ACOG 2011

Maternal consumption of omega-3 fatty acids during pregnancy reduces risk of childhood obesity

Columbia requests FDA Priority Review for PROCHIEVE progesterone gel NDA

Newer birth control pill raises risk of blood clots

Merck receives Health Canada approval for GARDASIL to treat HPV in women upto age 45

Fibulin-5 protein can help prevent pelvic organ prolapse development in women

Study: Women use more medications during pregnancy

Dactinomycin more effective for low-risk gestational tumor treatment

Mylan launches Letrozole Tablets for hormone receptor-positive early stage breast cancer

Planned Parenthood spends $400,000 on first-quarter lobbying

Rwanda, QIAGEN and Merck launch comprehensive national cervical cancer prevention program

Urologic Nursing publishes NAFC nocturia research in middle-aged American women

Political discourse regarding Planned Parenthood moves to states

CTIS Pregnancy Health Information Line aims to educate women about meningitis

Contraception drospirenone raises risk for blood clots

Merrimack initiates dosing in MM-111 combination Phase 1 study in advanced HER2 positive patients

Providing complete information about breast cancer treatment options often ends up overwhelming patients

US-LACRN selects Agilent gene expression microarrays for major breast cancer study

Roundup: Abortion opponents weigh strategy; Supreme Court reinstates case involving deaths at Va. hospitals

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News